Beyond Air Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
XAIR Nasdaq 3841 http://www.ait-pharm.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Beyond Air Inc

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022 - May 17th, 2022 8:05 pm
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer - May 17th, 2022 11:00 am
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast - May 16th, 2022 11:05 am
Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term - May 6th, 2022 10:29 am
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022 - Apr 25th, 2022 8:05 pm
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022 - Apr 25th, 2022 11:00 am
Beyond Air® to Participate in Three Upcoming Medical Conferences - Apr 18th, 2022 11:00 am
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect - Apr 11th, 2022 11:00 am
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting - Mar 8th, 2022 9:35 pm
Beyond Air (NASDAQ:XAIR) Is In A Good Position To Deliver On Growth Plans - Feb 22nd, 2022 9:52 am
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022 - Feb 10th, 2022 9:05 pm
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022 - Feb 8th, 2022 1:00 pm
Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors - Feb 3rd, 2022 9:05 pm
Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast - Jan 27th, 2022 1:00 pm
Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares - Dec 14th, 2021 2:15 pm
Implied Volatility Surging for Beyond Air (XAIR) Stock Options - Dec 10th, 2021 2:14 pm
Beyond Air® Provides Regulatory Update for LungFit® PH - Dec 9th, 2021 1:30 pm
Beyond Air Slides After LungFit Launch Delay - Dec 9th, 2021 10:56 am
Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer - Dec 1st, 2021 1:00 pm
Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement - Nov 18th, 2021 9:05 pm